Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
Markets Mostly Higher As Earnings Season Continues To Impress
Statement from FDA Confirms Approval of Gilead's Zydelig
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)
Related CELG
Biotech Enters Reporting Season With Large Caps Central To Sector Performance
UPDATE: Morgan Stanley Reiterates On Celgene As EU Patents Risk May Be Underappreciated
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas


Most Popular

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free